About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease 06-15-2022 at 7:30 AM EDT Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology 06-02-2022 at 4:10 PM EDT Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences 05-26-2022 at 8:00 AM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Goldman Sachs 43rd Annual Global Healthcare Conference Jun 15, 2022 at 1:00 PM EDT Listen to webcast William Blair 42nd Annual Growth Stock Conference Jun 8, 2022 at 4:20 PM EDT Listen to webcast William Blair 42nd Annual Growth Stock Conference Presentation 4.8 MB BofA Securities 2022 Healthcare Conference May 11, 2022 at 8:40 AM PDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jul 2, 2022 8:02 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
